News & Information
Ebola Reporting
Written by Editor   
Thursday, October 16, 2014 01:06 PM

Remembering that the favorite mantra of our medical cousins is "its not the money its the public safety",  here is reporting on the mercenary motives of many of our medical cousins.  "What was your reaction when you first realized that Ebola was killing thousands of people in Africa and would probably come ashore in America at some point? ... For some, it appears to have been,'How can I make money out of this?'"

"Numerous firms have begun marketing products to U.S. customers with Ebola-themed pitches. Last month, the FDA sent warning letters to three companies peddling a variety of products advertised as preventing or treating the disease -- one of them a chocolate bar."

Interesting: Ebola Evidence
Written by Editor   
Thursday, October 16, 2014 12:04 PM

Among all of the Ebola news that is going on out there here are some excerpts from various articles offering some interesting perspectives.  Among them are "Further supporting this genetic engineering research claim, the U.S. government patented Ebola in 2010 and now claims intellectual property ownership over all Ebola variants. That patent number is CA2741523A1, viewable at this link" which states, among other things

"The invention provides the isolated human Ebola (hEbola) viruses denoted as Bundibugyo (EboBun) deposited with the Centers for Disease Control and Prevention ("CDC"; Atlanta, Georgia, United States of America) on November 26, 2007 and accorded an accession number 200706291. ... Samples of the stated Deposit Accession No. 200706291 will be made available to approved facilities for thirty years from the date of deposit, and for the lifetime of the patent issuing from, or claiming priority to this application. ... The invention is related to compositions and methods directed to a novel species of human Ebola (hEbola) virus."

Standard Process Inc. Contributes to Raise Awareness for The Patriot Project
Written by Editor   
Tuesday, October 14, 2014 10:42 AM

A $5,000 donation from Standard Process Inc., manufacturer of nutritional supplements, will help the Patriot Project, a  grassroots movement to bring more awareness to the benefits chiropractic care can provide the nation’s military service men and women, active and retired, as well as their families, continue its mission.

Patriot Project founder, chiropractor Timothy P. Novelli, says efforts like Standard Process’ Pedal for Cause help raise awareness that chiropractic care can address optimum function and the health of the whole person, and especially for military service men and women. “Chiropractic physicians can fill a void in the military at home and on the battlefield,” said Novelli. “Anyone who carries an 80- to 120-pound pack along with body armor and a weapon in the toxic environment of war can benefit from chiropractic's whole body approach to health.”

'Medical Food' Bests Ibuprofen in Chronic Low Back Pain
Written by Editor   
Thursday, October 09, 2014 05:20 PM

Theramine, a "medical food" containing an amino acid blend (AAB), significantly improves chronic low back pain and reduces inflammation compared with low-dose ibuprofen, a nonsteroidal anti-inflammatory drug (NSAID), or a combination of these 2 treatments, results of a new study show. This is the second study looking at theramine in low back pain.

"Now we have done 2 multicenter, double-blind trials showing the effectiveness of theramine, not only on pain but also inflammation, and we are not seeing significant side effects," commented study author David S. Silver, MD, president and chief operating officer, Targeted Medical Pharma Inc, Los Angeles, California.

As a "medical food," theramine does not require US Food and Drug Administration preapproval; however, everything in the product must be GRAS (generally recognized as safe). "The claims [of a medical food] must be specifically for the nutritional management of a disease when a distinct nutritional requirement that cannot be met through regular diet is recognized." The claims of medical foods must be supported by clinical studies, unlike dietary supplements or nutraceuticals, which can't make disease claims and don't require clinical studies.

Financial Conflicts Tied to Influenza Drug Review Results
Written by Editor   
Thursday, October 09, 2014 05:17 PM

Systematic review authors with financial conflicts of interest are more likely to report favorably about the effects of neuraminidase inhibitors on the prevention and treatment of influenza than authors with no financial conflicts, according to an article published in the October 7 issue of the Annals of Internal Medicine.

Although previous studies have pointed to author financial conflicts of interest influencing the "production and synthesis of scientific evidence," this is the first study to apply specifically to neuraminidase inhibitors.

More Articles...
<< first < Prev 211 212 213 214 215 216 217 218 219 220 Next > last >>

Page 213 of 251